These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 19881253)
1. Paclitaxel-resistance conferred by altered expression of efflux and influx transporters for paclitaxel in the human hepatoma cell line, HepG2. Takano M; Otani Y; Tanda M; Kawami M; Nagai J; Yumoto R Drug Metab Pharmacokinet; 2009; 24(5):418-27. PubMed ID: 19881253 [TBL] [Abstract][Full Text] [Related]
2. Effect of Thai plant extracts on P-glycoprotein function and viability in paclitaxel-resistant HepG2 cells. Kawami M; Yumoto R; Nagai J; Junyaprasert VB; Soonthornchareonnon N; Patanasethanont D; Sripanidkulchai BO; Takano M Drug Metab Pharmacokinet; 2010; 25(2):155-62. PubMed ID: 20460821 [TBL] [Abstract][Full Text] [Related]
3. Modulation of P-glycoprotein function and multidrug resistance in cancer cells by Thai plant extracts. Takano M; Kakizoe S; Kawami M; Nagai J; Patanasethnont D; Sripanidkulchai B; Yumoto R Pharmazie; 2014 Nov; 69(11):823-8. PubMed ID: 25985578 [TBL] [Abstract][Full Text] [Related]
4. Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells. Kamioka H; Edaki K; Kasahara H; Tomono T; Yano K; Ogihara T J Pharm Pharmacol; 2021 Dec; 73(12):1609-1616. PubMed ID: 34313784 [TBL] [Abstract][Full Text] [Related]
5. Expression of organic anion-transporting polypeptides 1B1 and 1B3 in ovarian cancer cells: relevance for paclitaxel transport. Svoboda M; Wlcek K; Taferner B; Hering S; Stieger B; Tong D; Zeillinger R; Thalhammer T; Jäger W Biomed Pharmacother; 2011 Sep; 65(6):417-26. PubMed ID: 21719246 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma. Liu B; Staren ED; Iwamura T; Appert HE; Howard JM J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885 [TBL] [Abstract][Full Text] [Related]
7. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor. Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233 [TBL] [Abstract][Full Text] [Related]
8. Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells. Zhang DM; Li YJ; Shu C; Ruan ZX; Chen WM; Yiu A; Peng YH; Wang J; Lan P; Yao Z; Fung KP; Fu LW; Chen ZS; Ye WC Anticancer Drugs; 2013 Jun; 24(5):441-54. PubMed ID: 23466650 [TBL] [Abstract][Full Text] [Related]
9. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Chavanpatil MD; Patil Y; Panyam J Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148 [TBL] [Abstract][Full Text] [Related]
11. Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells. Ehrlichova M; Vaclavikova R; Ojima I; Pepe A; Kuznetsova LV; Chen J; Truksa J; Kovar J; Gut I Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):95-105. PubMed ID: 16059735 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity. Tanino T; Nawa A; Kondo E; Kikkawa F; Daikoku T; Tsurumi T; Luo C; Nishiyama Y; Takayanagi Y; Nishimori K; Ichida S; Wada T; Miki Y; Iwaki M Pharm Res; 2007 Mar; 24(3):555-65. PubMed ID: 17245652 [TBL] [Abstract][Full Text] [Related]
14. P-gp modulating effect of Kawami M; Yamada Y; Issarachot O; Junyaprasert VB; Yumoto R; Takano M Pharmazie; 2018 Feb; 73(2):104-109. PubMed ID: 29442013 [TBL] [Abstract][Full Text] [Related]
15. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells. Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901 [TBL] [Abstract][Full Text] [Related]
16. Identification of Transporters Involved in Beraprost Sodium Transport In Vitro. Oshida K; Shimamura M; Seya K; Ando A; Miyamoto Y Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):117-128. PubMed ID: 26961540 [TBL] [Abstract][Full Text] [Related]
17. Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein. Xiang QF; Zhang DM; Wang JN; Zhang HW; Zheng ZY; Yu DC; Li YJ; Xu J; Chen YJ; Shang CZ Liver Int; 2015 Mar; 35(3):1010-23. PubMed ID: 24621440 [TBL] [Abstract][Full Text] [Related]
18. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Huisman MT; Chhatta AA; van Tellingen O; Beijnen JH; Schinkel AH Int J Cancer; 2005 Sep; 116(5):824-9. PubMed ID: 15849751 [TBL] [Abstract][Full Text] [Related]
19. Function and expression of ATP-binding cassette transporters in cultured human Y79 retinoblastoma cells. Ishikawa Y; Nagai J; Okada Y; Sato K; Yumoto R; Takano M Biol Pharm Bull; 2010; 33(3):504-11. PubMed ID: 20190417 [TBL] [Abstract][Full Text] [Related]
20. Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism. Xu Q; Guo J; Chen W Biochem Biophys Res Commun; 2019 Jan; 508(3):882-888. PubMed ID: 30538042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]